pillbase.ru

ZYNRELEF

Active substance: BUPIVACAINE, MELOXICAM

SOLUTION · BUPIVACAINE 200 mg/7mL, MELOXICAM 6 mg/7mL

United StatesActive

Marketing holder: Heron Therapeutics, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing bupivacaine in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
EU 2
  • Exparel liposomal
    bupivacaine
    EMEA/H/C/004586
    Pacira Ireland Limited
  • Zynrelef
    bupivacaine, meloxicam
    EMEA/H/C/005205
    Heron Therapeutics, B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2b18-7992-a256-3f721e87f5d3,01a1208c-2cc5-76e8-b7a3-224fee97fb73,01a1208c-3235-73cf-be27-5f838bcae0b3,01a1208c-3bf1-701c-aadb-57367f601fcc,01a1208c-3bf3-722a-9932-82c5be51027a;count=111 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
47426-503
Registration status
Active
Dispensing
Prescription only
Route
INFILTRATION
Sources
  • product · openFDA NDC · 47426-503 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 47426-503 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 47426-503 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 47426-503 · Verified 2026-10-09 · open in source